Califano Testifies Before Senate on New CASA* White Paper Finding 70% Rise in Web Sites Advertising, Selling Prescription Opioids, Stimulants, Depressants | CASAColumbia

Califano Testifies Before Senate on New CASA* White Paper Finding 70% Rise in Web Sites Advertising, Selling Prescription Opioids, Stimulants, Depressants

Califano Testifies Before Senate on New CASA* White Paper Finding 70% Rise in Web Sites Advertising, Selling Prescription Opioids, Stimulants, Depressants

WASHINGTON, D.C., May 16, 2007

For three years straight the number of rogue Web sites selling controlled prescription drugs like OxyContin, Vicodin, Valium, and Ritalin has increased, according to a new white paper released by The National Center on Addiction and Substance Abuse (CASA) at Columbia University.

The white paper, “You’ve Got Drugs!” IV: Prescription Drug Pushers on the Internet, to be released today at the U.S. Senate Judiciary Committee hearing on “Rogue Online Pharmacies: The Growing Problem of Internet Drug Trafficking,” found a total of 581 Web sites advertising or selling controlled prescription drugs in 2007 compared to 342 sites in 2006.

Sites advertising controlled prescription drugs increased by 135%, from 168 in 2006 to 394 in 2007. Sites selling these drugs increased by 7% from 174 in 2006 to 187 in 2007. Of the 187 sites found selling controlled prescription drugs this year, only 2 were certified by the National Association of Boards of Pharmacy as Verified Internet Pharmacy Practice SitesTM.

“The easy availability of addictive opioids, depressants and stimulants has, for many children, made the Internet a greater threat than the illegal street drug dealer,” said Joseph A. Califano, Jr., CASA’s Chairman and President and former U.S. Secretary of Health, Education, and Welfare. “The Internet has become a pharmaceutical candy store stocked with addictive drugs, available at the click of a mouse to any kid with a credit card number.”

Other findings in the white paper include:

  • 84% of sites selling these drugs did not require a prescription
  • Of the 16% that claimed to require a prescription, most (57%) simply ask that it be faxed, allowing a customer to forge it or use the same prescription many times to load up on these drugs
  • Over the past four years, the number of sites selling controlled prescription drugs has increased steadily from 154 in 2004 and 2005 to 187 in 2007
  • Benzodiazepines (Xanax and Valium) continue to be the most frequently offered controlled prescription drug, sold on 79% of the sites; followed by opioids (Vicodin and OxyContin) on 64% of the sites
  • There are no controls stopping sale of these drugs to children

Among the CASA white paper recommendations:

  • Clarifying federal law to prohibit sale or purchase of controlled prescription drugs on the Internet without an original copy of a prescription issued by a DEA certified physician, licensed in the state of purchase, based on a physical examination and evaluation
  • Requiring certification of online pharmacies to assure that they meet rigorous standards of professional practice

For four years CASA, in collaboration with Beau Dietl & Associates, has been tracking online access to controlled prescription drugs, performing the same analysis over the course of a comparable period. The 581 sites represent the number documented in 210 hours in the first quarter of the year as offering opioids, depressants and stimulants.

In 2004 CASA released “You’ve Got Drugs!” I: Prescription Drug Pushers on the Internet, which found the Internet to be a wide-open channel for distribution of dangerous and addictive prescription drugs. In 2005 CASA released Under the Counter: The Diversion and Abuse of Controlled Prescription Drugs in the U.S., which found that between 1992 and 2003, while the U.S. population increased 14%, the number of Americans abusing these drugs rose 94% and the number of 12- to 17-year olds admitting to such drug abuse jumped 212%.

CASA is the only national organization that brings together under one roof all the professional disciplines needed to study and combat all types of substance abuse as they affect all aspects of society. CASA has issued 64 reports and white papers, published one book, conducted demonstration projects focused on children, families and schools at 190 sites in 72 cities and counties in 29 states plus Washington, DC and a Native American tribal reservation, and has been evaluating the effectiveness of drug and alcohol treatment, in a variety of programs and drug courts. For more information visit www.CASAColumbia.org.

*The National Center on Addiction and Substance Abuse at Columbia University is neither affiliated with, nor sponsored by, the National Court Appointed Special Advocate Association (also known as "CASA") or any of its member organizations with the name of "CASA."

Media

Director of Communications

(212) 841.5260

lduran@CASAColumbia.org

Communications Specialist

(212) 841.5209

amcsherry@CASAColumbia.org

Marketing

Director of Marketing

(212) 841.5252

kmanning@CASAColumbia.org

Digital

Manager of Digital Strategy

(212) 841.5225

aroley@CASAColumbia.org

Newsletter Additional Information

Newsletter Additional Information

Thank you for subscribing

This information will be used to better customize your experience and help inform future tools and features on our website.

Additonal Information
WHICH OF CASAColumbia's ISSUES INTEREST YOU?
Profession